Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Simon Fraser University

$15,000.00

Data analyses, interim reviews and design issues of longitudinal study in biomedical research

EF 2006-07

Résumé
Many biomedical studies are concerned with the development of persons or groups over time. The broad objective of this research is to develop new theory and methods for analyzing data from longitudinal study and for study design and monitoring. Since available therapies, biological knowledge, and standard of care are rapidly evolving and thus relatively little may be known about the nature and magnitude of the expected treatment effect and about the clinical significance of certain types of differences in the outcome measure, approaches with modest model assumption are desirable in many health studies. The first specific objective is further development of robust statistical approaches to quantifying the time trend and association between variables over time from the collected longitudinal data. The ethical and economic considerations in the design of clinical trials to evaluate the efficacy and possible toxicity effects of new therapies, together with the inherent sequential nature of the information flow during the longitudinal trials, are responsible for the increasing interest in group sequential methods for monitoring the studies and for providing studies with adaptive designs. Our second specific objective is to fill out the development of the repeated confidence bands approach for formal reviews in clinical trials, and to provide study designs with efficient adaptation of the available information. The third specific objective is to develop regression analysis methods in the situations with longitudinal response, possibly incomplete, and a large number of explanatory variables. This is motivated by the scientific interest in establishing the association between disease progression and clinical outcome over time and patient's biomarker or gene expression data. The research results, illustrated with their applications to recent medical studies, will be disseminated to medical investigators and biostatistical practitioners via publications, conferences and software distribution. In addition, the students involved will be well-prepared to meet the various demands of statistical support in practice, particularly in medical settings.
Programme
Discovery Grants Program - Individual
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
262823-2006
Name nom
Hu, Joan
Department département
Statistics & Actuarial Science
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2006
Competition year année de concours
2006
Award amount
15000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
14
Committee name en
Statistical Sciences
Committee name fr
Statistique
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3005
Research subject group en
Statistics and probability
Research subject group fr
Statistique et probabilité
Research subject en
Biostatistics
Research subject fr
Biostatistiques
Partie
1
Nb partie
5
Application title
Data analyses, interim reviews and design issues of longitudinal study in biomedical research
Keyword
NA
Application summary
Many biomedical studies are concerned with the development of persons or groups over time. The broad objective of this research is to develop new theory and methods for analyzing data from longitudinal study and for study design and monitoring. Since available therapies, biological knowledge, and standard of care are rapidly evolving and thus relatively little may be known about the nature and magnitude of the expected treatment effect and about the clinical significance of certain types of differences in the outcome measure, approaches with modest model assumption are desirable in many health studies. The first specific objective is further development of robust statistical approaches to quantifying the time trend and association between variables over time from the collected longitudinal data. The ethical and economic considerations in the design of clinical trials to evaluate the efficacy and possible toxicity effects of new therapies, together with the inherent sequential nature of the information flow during the longitudinal trials, are responsible for the increasing interest in group sequential methods for monitoring the studies and for providing studies with adaptive designs. Our second specific objective is to fill out the development of the repeated confidence bands approach for formal reviews in clinical trials, and to provide study designs with efficient adaptation of the available information. The third specific objective is to develop regression analysis methods in the situations with longitudinal response, possibly incomplete, and a large number of explanatory variables. This is motivated by the scientific interest in establishing the association between disease progression and clinical outcome over time and patient's biomarker or gene expression data. The research results, illustrated with their applications to recent medical studies, will be disseminated to medical investigators and biostatistical practitioners via publications, conferences and software distribution. In addition, the students involved will be well-prepared to meet the various demands of statistical support in practice, particularly in medical settings.